Yet, the power of these strategies allowed the identification of at least two novel genes in EOAD genetics with a demonstrated functional effect (VPS35 and MARK4) [148], one in ALS (SS18L1) [37], and one recently in PD (NUS1) [58]. The gene discussed is VPS35; the disease is Parkinson disease.